Verkäufer
ThriftBooks-Atlanta, AUSTELL, GA, USA
Verkäuferbewertung 5 von 5 Sternen
AbeBooks-Verkäufer seit 24. März 2009
May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.98. Bestandsnummer des Verkäufers G8416153930I4N00
Titel: CARDIO ONCOLOGY
Verlag: Cto Editorial SL
Erscheinungsdatum: 2015
Einband: Hardcover
Zustand: Very Good
Zustand des Schutzumschlags: No Jacket
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 120 pages. 9.00x6.00x0.28 inches. In Stock. Artikel-Nr. zk1656292718
Anzahl: 1 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 120 pages. 9.00x6.00x0.28 inches. In Stock. Artikel-Nr. zk1656292688
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Artikel-Nr. 401082538
Anzahl: 1 verfügbar
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. Brand New. Soft Cover International Edition. Different ISBN and Cover Image. Priced lower than the standard editions which is usually intended to make them more affordable for students abroad. The core content of the book is generally the same as the standard edition. The country selling restrictions may be printed on the book but is no problem for the self-use. This Item maybe shipped from US or any other country as we have multiple locations worldwide. Artikel-Nr. ABNR-309911
Anbieter: SpringBooks, Berlin, Deutschland
Softcover. Zustand: Very Good. 1. Auflage. Unread, some shelfwear. Immediately dispatched from Germany. Artikel-Nr. CE-2403C-STAPEL-089-0500k
Anzahl: 1 verfügbar
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 272 | Sprache: Englisch | Produktart: Bücher | This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them. Artikel-Nr. 25324214/12
Anzahl: 1 verfügbar
Anbieter: SpringBooks, Berlin, Deutschland
Hardcover. Zustand: As New. 1. Auflage. Unread, like new. Immediately dispatched from Germany. Artikel-Nr. CEA-2311C-DVD-02-1000XS
Anzahl: 1 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. Neuware -Introduction Cardiovascular management of cancer patients represents a major challenge, since cancer and cardiovascular disease often coexist, and anticancer treatments can be the cause of cardiac or vascular toxicity. It is therefore vital to specifically organize cardiovascular follow-up for patients who are due to receive potentially cardio-toxic treatment. Improved management and the development of specific research require teams and structures bringing together cardiologists and oncologists, who have acquired interdisciplinary expertise. In this context, the creation of a cardio-oncology unit has emerged.Methods In this paper, we examine the managerial and academic aspects of a project to set up a cardio-oncology unit in the cardiology department of the Tunis Military Hospital.Results An inventory of the difficulties involved in caring for cancer patients was drawn up using an ISHIKAWA diagram. Among the obstacles identified, poor knowledge of anticancer treatments and their toxicities, as well as the absence of close collaboration between the different medical teams, were cited.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 56 pp. Englisch. Artikel-Nr. 9786206222767
Anzahl: 2 verfügbar
Anbieter: LiLi - La Liberté des Livres, CANEJAN, Frankreich
Zustand: very good. Le livre peut montrer des signes d'usure dus a une utilisation constante, etre marque, porter des marques d'identification ou presenter plusieurs dommages esthetiques mineurs. vendeur professionnel; envoi soigne en 24/48h. Artikel-Nr. 2410290002772
Anzahl: 1 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Cardiac Management of Oncology Patients | Clinical Handbook for Cardio-Oncology | Riccardo Asteggiano (u. a.) | Taschenbuch | ix | Englisch | 2015 | Springer International Publishing | EAN 9783319158075 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Artikel-Nr. 104911389
Anzahl: 5 verfügbar